L’Oreal

...

Dan Cody

By Dan Cody

Digital Media Reporter

0

Share

Newsweek is a Trust Project member

See more of our trusted coverage when you search.Prefer Newsweek on Googleto see more of our trusted coverage when you search.


L'Oréal has voluntarily recalled all of its Effaclar Duo acne treatment in the U.S. due to concerns that the product may be contaminated with benzene, a known carcinogen.

"In close coordination with the FDA, we have proactively decided to remove the limited remaining units of the current formula of Effaclar Duo from retailers," L'Oréal said in a statement to Bloomberg.

What Are the Health Risks of Benzene?

Benzene is a well-documented carcinogen that has been linked to leukemia and other blood disorders with prolonged exposure, according to the American Cancer Society (American Cancer Society). The chemical is found in crude oil, gasoline and tobacco smoke and is also used in industrial manufacturing.

Read More on News

L’Oreal

...

The Centers for Disease Control and Prevention (CDC) warns that benzene exposure can occur through inhalation, ingestion, or skin absorption. Long-term exposure to high levels of benzene can damage bone marrow, leading to anemia and an increased risk of leukemia, particularly acute myeloid leukemia.

Benzoyl peroxide, the active ingredient in Effaclar Duo, can degrade over time and form benzene when exposed to heat or improper storage conditions.

L'Oréal's Response

The Effaclar Duo acne treatment, which is sold under L'Oréal's La Roche-Posay brand, contains 5.5% micronized benzoyl peroxide and is marketed as "our best spot treatment for acne" with claims of "fast and visible results in less than 3 days," according to the company's website​.

Although the recall is voluntary, L'Oréal has not disclosed whether it will reformulate the product or when it will return to store shelves. The company confirmed that it is working with the U.S. Food and Drug Administration (FDA) to address the contamination concerns.

The FDA has not issued an official statement on the recall, but previously received a citizen petition urging regulatory action on benzoyl peroxide products. However, the agency responded that it was still conducting its own review and analysis of the contamination issue.

Contamination in Personal Care Products

This is not the first time benzene has been detected in widely used personal care products. Over the past several years, benzene contamination has led to recalls of sunscreens, antiperspirants, dry shampoos and hand sanitizers after independent lab testing found unsafe levels of the chemical in multiple products sold in U.S. stores, the New York Post reported​.

The FDA has issued multiple warnings in the past regarding the risks of benzene exposure, particularly in aerosol-based and topical formulations. However, no federal regulations currently require routine benzene testing for acne treatments, which has raised concerns among some consumer advocacy groups.

FDA Oversight and Potential Impact

The FDA hasn't announced whether additional benzoyl peroxide-based acne treatments will be recalled. The agency has previously taken action against benzene contamination in other personal-care products, including sunscreens, dry shampoos and hand sanitizers.

FDA Commissioner Dr. Robert Califf acknowledged that benzene exposure remains a serious public health concern. "The FDA continues to assess the risks associated with benzene contamination in consumer products," he said, according to Fortune. "We are working with industry stakeholders and independent labs to better understand how and why this contamination occurs."

Benzene contamination in over-the-counter and prescription skincare products could lead to stricter FDA oversight, particularly in stability testing requirements for products containing benzoyl peroxide. The agency has not ruled out the possibility of additional recalls in the coming months.

Consumer Concerns and Next Steps

L'Oréal has removed the Effaclar Duo product from store shelves, but has not publicly advised consumers to stop using it. The recall was confirmed in multiple reports, but no consumer warning has been issued directly by the company regarding discontinuation of use, according to the New York Post​.

View 0 Comments

Request Reprint & Licensing

Submit Correction

View Editorial & AI Guidelines